Pacira BioSciences (PCRX) Other financing activities (2010 - 2017)

Pacira BioSciences (PCRX) recorded quarterly Other financing activities of $11.0 million in Q1 2017, up 52.97% quarter-over-quarter from $7.2 million in Q1 2013.

Pacira BioSciences (PCRX) Other financing activities (2010 - 2017) Analysis & Trends

Pacira BioSciences' Other financing activities history runs 5 years deep, the most recent figure standing at $11.0 million for Q1 2017.

  • In Q1 2017, Other financing activities changed N/A year-over-year to $11.0 million; the TTM figure through Dec 2017 stood at $11.0 million (changed N/A YoY), while the FY2022 annual figure was $1.2 million, down 74.15% from the prior year.
  • Other financing activities was $11.0 million for Q1 2017 at Pacira BioSciences, up from $7.2 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $11.0 million in Q1 2017 to a low of $7.2 million in Q1 2013.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Pacira BioSciences 940.31 Mn 738.13 Mn 140.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2017 11.00 Mn
Mar 31, 2017 11.00 Mn
Mar 31, 2013 7.19 Mn
Mar 31, 2013 7.19 Mn
Jun 30, 2012 1.02 Mn
Jun 30, 2012 1.02 Mn
Mar 31, 2012 348,000.00
Mar 31, 2012 348,000.00
Mar 31, 2011 907,000.00
Mar 31, 2011 907,000.00
Dec 31, 2010 1.43 Mn
Dec 31, 2010 1.43 Mn